REFERENCES
- Drug Enforcement Administration. Lists of: Scheduling Actions, Controlled Substances, Regulated Chemicals. 2011. Available at: http://www.deadiversion.usdoj.gov/schedules/orangebook/orangebook.pdf. Accessed April 5, 2012.
- Substance Abuse and Mental Health Services Administration. Drug Abuse Warning Network (DAWN): Detailed tables: Drug-Related Emergency Department Visits for 2004–2009. 2010. Available at: http://dawninfo.samhsa.gov/data./ Accessed Dec 20, 2011.
- Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. (July 2, 2012). The DAWN Report: Highlights of the 2010 Drug Abuse Warning Network (DAWN) Findings on Drug-Related Emergency Department Visits. Rockville, MD. Available at: http://www.samhsa.gov/data/2k12/DAWN096/SR096EDHighlights2010.htm. Accessed July 27, 2012.
- Paulozzi LJ, Weisler RH, Patkar AA. A national epidemic of unintentional prescription opioid overdose deaths: how physicians can help control it. J Clin Psychiatry. 2011;72:589–592.
- Centers for Disease Control and Prevention. Morbidity and Mortality Weekly Report, Vol. 60 (No. 43), 2011. Available at: http://www.cdc.gov/mmwr/pdf/wk/mm6043.pdf. Accessed February 18, 2012.
- Substance Abuse and Mental Health Services Administration. Results from the 2010 National Survey on Drug Use and Health: National Findings. Washington, DC: Office of Applied Studies; 2011. NSDUH Series H-36, HHS Publication SMA 09–4434. Available at: http://oas.samhsa.gov/NSDUH/2k10NSDUH/2k10Results.htm#2.16. Accessed December 11, 2011.
- Birnbaum HG, White AG, Schiller M, Waldman T, Cleveland JM, Roland CL. Societal costs of prescription opioid abuse, dependence, and misuse in the United States. Pain Med. 2011;12:657–667.
- Centers for Disease Control and Prevention. Morbidity and Mortality Weekly: Drug Overdose Deaths: Florida, 2003–2009. 2011. Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6026a1.htm. Accessed March 14, 2012.
- Florida Legislature. An act (HB 7095) relating to prescription drugs, Chapter 2011–141, amending Florida Statute Sec. 456.072. 2011. Available at: http://laws.flrules.org/files/Ch_2011–141.pdf. Accessed March 14, 2012.
- House of Representatives, Subcommittee on Commerce, Manufacturing and Trade, Committee on Energy and Commerce; 111 Congress, 2d Sess. Prescription Drug Diversion: Combatting the Scourge. Washington, DC; 2012, March 1.
- State of Florida. Final Bill Analysis, HB 7095 (A bill to address the problem of prescription drug abuse in Florida), approved June 3 to take effect July 1. 2011. Available at: http://flsenate.gov/Session/Bill/2011/7095/Analyses/mFIFGjeIUCMPbRDs8 dvfZcyc2VA=%7C7/Public/Bills/7000–7099/7095/Analysis/h7095z.HHSC.PDF. Accessed May 7, 2012.
- State of Florida. House Bill 7095: An act relating to prescription drugs; amending s. 456.072. 2011. Available at: http://flsenate.gov/Session/Bill/2011/7095. Accessed Feb 10, 2012.
- Florida Legislature. An act (HB 7095) relating to prescription drugs, Chapter 2011–141, amending Florida Statute Sec. 456.072; Section 15(3)(b), Due diligence of purchasers. 2011. Available at: http://laws.flrules.org/files/Ch_2011–141.pdf. Accessed June 8, 2012.
- Drug Enforcement Administration. DEA Registrant Population. 2012. Available at: https://www.deadiversion.usdoj.gov/webforms/odrBusActReportSelect.do. Accessed June 10, 2012.
- Federal Register. Definition and Registration of Reverse Distributors. Vol. 70 (May 1), 70 FR 22591. 2005. Available at: http://frwebgate2.access.gpo.gov/cgi-bin/PDFgate.cgi?WAISdocID = pHkskU/1/2/0&WAISaction = retrieve. Accessed March 14, 2012.
- 21 USC 823. Registration requirements. 2010. Available at: http://www.gpo.gov/fdsys/pkg/USCODE-2010-title21/pdf/USCODE-2010-title21-chap13.pdf. Accessed June 2, 2012.
- DEA Lookup.com. Pharmaceutical Distributors Directory. 2012. Available at: http://www.dealookup.com/pharmaceutical-distributors.asp. Accessed May 11.
- Britt R. Special Report: Growing share of ‘Big Three’ gets federal attention; Giant wholesalers dominate market, to hit quarter-trillion mark in sales. MarketWatch; The Wall Street Journal (May 30). 2007. Available at: http://articles.marketwatch.com/2007-05-30/news/30788055_1_wholesale-drug-market-reimportation-mckesson-and-cardinal Accessed July 27, 2012.
- 21 CFR 1301.74. Food and Drugs, Part 1300 to End. 2011. Available at: http://www.gpo.gov/fdsys/pkg/CFR-2011-title21-vol9/pdf/CFR-2011-title21-vol9-part1301.pdf. Accessed March 27, 2012.
- Controlled Substances Act. Title 21, United States Code, Sect. 8271970.
- Drug Enforcement Administration. Automation of Reports and Consolidated Orders System (ARCOS); Background: What is ARCOS and What Does it Do? 2012. Available at: http://www.deadiversion.usdoj.gov/arcos/index.html. Accessed April 8, 2012.
- ARCOS Unit, DEA Headquarters. Automation of Reports and Consolidated Orders System (PowerPoint presentation). 14th Pharmaceutical Industry Conference, Portland, OR, October 14–15, 2009. 2009. Available at: http://www.deadiversion.usdoj.gov/mtgs/pharm_industry/14th_pharm/gun- thropes.pdf. Accessed March 15, 2012.
- Federal Register. Southwood Pharmaceuticals, Inc. Revocation of Registration (72 FR 36487). 2007. Available at: http://www.gpoaccess.gov/fr/. Accessed March 15, 2012.
- McKesson Corporation. McKesson Announces Settlement with DEA. 2008. Available at: http://www.mckesson.com/en_us/ McKesson.com/About%2BUs/Newsroom/Press%2BReleases% 2BArchives/2008/McKesson%2BAnnounces%2BSettlement% 2Bwith%2BDEA.html. Accessed April 2, 2012.
- Drug Enforcement Administration. DEA News: McKesson Corporation Agrees to Pay More Than $13 Million to Settle Claims That It Failed to Report Suspicious Sales of Prescription Medications. 2008. Available at: http://www.justice.gov/dea/pubs/pressrel/pr050208.html. Accessed April 2, 2012.
- Cardinal Health Inc. v. Eric Holder, Jr., Attorney General, et al. U.S. District Court, District of Columbia, Case 1:12-cv-00185-RBW; Document 14–2; Filed 02/10/12 at p. 18. Washington, D.C. 2012.
- Cardinal Health Inc. v. Eric Holder, Jr., Attorney General, et al. U.S. District Court, District of Columbia, Case 1:12-cv-00185-RBW; Document 14–2; Filed 02/10/12 at p. 19. Washington, D.C. 2012.
- Cardinal Health Inc. v. Eric Holder, Jr., Attorney General, et al. U.S. District Court, District of Columbia, Case 1:12-cv-00185-RBW; Document 14–18; Filed 02/10/12 at pp. 2–6. Washington, D.C. 2012.
- Cardinal Health Inc. v. Eric Holder, Jr., Attorney General, et al. U.S. District Court, District of Columbia, Case 1:12-cv-00185-RBW; Document 14–2; Filed 02/10/12. Washington, D.C. 2012.
- Cardinal Health, Inc. Cardinal Health Brings Resolution to Litigation with DEA Settlement. 2012. Available at: http://cardinalhealth.mediaroom.com/index.php?s = 43&item = 475. Accessed May 15, 2012.
- Drug Enforcement Administration. DEA Suspends for Two Years Pharmaceutical Wholesale Distributor's Ability to Sell Controlled Substances from Lakeland, Florida Facility. 2012. Available at: http://www.justice.gov/dea/pubs/pressrel/pr051512.html. Accessed May 15, 2012.
- Drug Enforcement Administration. News Release: DEA Suspends Orlando Branch of Drug Company from Distributing Controlled Substances. 2007. Available at: http://www. justice.gov/dea/pubs/states/newsrel/mia042407.html. Accessed March 25, 2012.
- Federal Register. Southwood Pharmaceuticals, Inc. Revocation of Registration (72 FR 36487) at p. 36500. 2007. Available at: http://www.gpoaccess.gov/fr./ Accessed March 15, 2012.
- Drug Enforcement Administration. Administrative Memorandum of Agreement & Stipulation and Agreement between U.S. Department of Justice, DEA and Southwood Pharmaceuticals, Inc. (unpub l.). 2008.
- Drug Enforcement Administration. Supplier of Internet Pharmacies Faces Possible Action by DEA: Masters Pharmaceutical Ordered to Show Cause. 2008. Available at: http://www.justice.gov/dea/pubs/states/newsrel/2008/detroit 110408b.html. Accessed March 14, 2012.
- Business Courier. Masters Pharmaceutical Fined by DEA. 2009. Available at: http://www.bizjournals.com/cincinnati/stories/2009/05/04/daily9.html. Accessed March 14, 2012.
- LaMendola B. DEA accuses sunrise company of supplying painkillers to ‘pill mills’. Sun Sentinel. 2010; June 22: Available at: http://articles.sun-sentinel.com/2010-06-22/business/fl-drug-wholesaler-stopped-20100621_1_pill-mills-pain-clinics-dea-official. Accessed on July 27, 2012.
- United States Bankruptcy Court, Southern District of Florida (Ft. Lauderdale Div.). Bankruptcy Case No. 12–12983, In re: Sunrise Wholesale, Inc. (Chap. 7); filed February 7, 2012.
- Harvard Drug Group LLC. Harvard Drug Announces DEA Agreement. 2011. Available at: http://www.theharvarddruggroup.com/pdf/DEA_Agreement.pdf. Accessed March 22, 2012.
- KeySource Medical v. Eric Holder, Attorney General of the United States. Order Denying Plaintiff's Motion for Temporary Restraining Order and for Preliminary Injunction. Case 1:11-cv-00393-SJD; Document No. 22; Filed 08/16/11 at p. 5 of 16; U.S. District Court, Southern District of Ohio, 2011.
- Drug Enforcement Administration. DEA Investigation: Cincinnati Pharmaceutical Distributor Fails to Guard Against Diversion of Controlled Substances, Pays $320,000 Settlement: Largest Independent Supplier of Oxycodone to Florida in 2010. 2012. Available at: http://www.justice.gov/dea/pubs/states/newsrel/2012/det040512.html. Accessed June 8, 2012.
- United States of America ex rel. Donald GALE vs. Omnicare, Inc. Complaint filed 1/19/2010 in Case 1:10-cv-00127-CAB, United States District Court for the Northern District of Ohio (Eastern Division), Document No. 1, Page 2 of 42; 2010.
- U.S. Securities and Exchange Commission. Form 10Q: Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934; For the period ended September 30, 2010 (p. 26). 2010. Available at: http://www.sec.gov/Archives/edgar/data/353230/000144264310000059/form10q-3q.htm. Accessed June 8, 2012.
- Drug Enforcement Administration. Omnicare in $50 Million Settlement—Largest Controlled Substance Settlement in History—Controlled Substances Allegedly Improperly Dispensed at Nursing Homes. 2012. Available at: http://www.justice.gov/dea/pubs/states/newsrel/2012/det051112.html. Accessed June 8, 2012.
- Healthcare Distribution Management Association. Statement from John M. Gray, President and CEO, Healthcare Distribution Management Association, given before the U.S. House of Representatives, Energy and Commerce Committee, Subcommittee on Commerce, Manufacturing, and Trade. 2012. Available at: http://www.healthcaredistribution.org/testimony/ 2012–03–01_gray_testimony.pdf. Accessed May 12, 2012.
- 21 USC 876. Administrative and Enforcement Procedures: Subpenas. 2010. Available at: http://www.gpo.gov/fdsys/ pkg/USCODE-2010-title21/pdf/USCODE-2010-title21-chap13.pdf. Accessed March 25, 2012.
- 21 CFR 1316. Food and Drugs, Part 1300 to End. 2011. Available at: http://www.gpo.gov/fdsys/pkg/CFR-2011-title21-vol9/pdf/CFR-2011-title21-vol9-part1308-toc-id200.pdf. Accessed March 27, 2012.
- Holiday CVS, L.L.C., d/b/a CVS Pharmacy Nos. 5195/219 v. Michelle Leonhart, In her official capacity as Administrator of the Drug Enforcement Administration, et al. U.S. District Court, District of Columbia, Case 1:12-cv-00191-RBW; Document 5; Filed 02/07/12 at pp. 12–13. Washington, D.C. 2012.
- Holiday CVS, L.L.C. d/b/a CVS/pharmacy No. 5195 and No. 219 vs. Eric H. Holder, Jr., et al. U.S. District Court, District of Columbia, Case 1:12-cv-00191-RBW. 2012.
- Drug Enforcement Administration. ARCOS Registration Handbook. 1997. Available at: http://www.deadiversion.usdoj. gov/arcos/handbook/full.pdf. Accessed May 15, 2012.
- Healthcare Distribution Management Association. America's Healthcare Distributors: The Vital Link. 2012. Available at: http://www.healthcaredistribution.org/press_room/pdf/vitallink_ 092705.pdf. Accessed May 28.
- Kolassa EM. The Strategic Pricing of Pharmaceuticals. Gilsum, NH: The PondHouse Press; 2009.
- Jacobsen TM, Wertheimer AI. Modern Pharmaceutical Industry. Sudbery, MA: Jones & Bartlett; 2010.
- Burns LR. The Health Care Value Chain: Producers, Purchasers, and Providers. San Francisco: Jossey-Bass; 2002.
- Whewell R. Supply Chain in the Pharmaceutical Industry. Surrey, UK: Gower Publishing; 2010.
- Siecker BR. Trends in drug distribution channels and practices. In: Smith MC, ed. Pharmaceutical Marketing in the 21st Century. New York: Pharmaceutical Products Press (The Haworth Press); 1996:207–221.
- Cardinal Health Inc. v. Eric Holder, Jr., Attorney General, et al. U.S. District Court, District of Columbia, Case 1:12-cv-00185-RBW; Document 14–2; Filed 02/10/12 at pp. 22–23. Washington, D.C. 2012.
- Harper K. Mallinckrodt LLC (“A Covidien Company”) letter of September 16 and 19 sent to 43 distributors. Filed 2/10/12 as Document 14–16 in Cardinal Health Inc. v. Eric Holder, Jr., Attorney General, et al., Civil Action No. 1:12-cv-00185-RBW; U.S. District Court, District of Columbia, 2011.
- Cardinal Health Inc. v. Eric Holder, Jr., Attorney General, et al. U.S. Court of Appeals, District of Columbia, Case 12–5061; Document 1362896; Filed 03/09/2012 at pp. 10–11 of 25. Washington, D.C. 2012.
- Coglianese C, Healey TJ, Keating EK, Michael ML. “The Role of Government in Corporate Governance” Regulatory Policy Program Report RPP-08 (2004), Cambridge, MA: Center for Business and Government, John F. Kennedy School of Government, Harvard University. http://www.hks.harvard.edu/m-rcbg/research/rpp/reports/RPPREPORT8.pdf. Accessed May 29, 2012.
- CVS Caremark. CVS/Pharmacy Announces Agreements With U.S. Drug Enforcement Administration and U.S. Attorneys’ Offices. 2010. Available at: http://info.cvscaremark.com/ newsroom/press-releases/cvspharmacy-announces-agreements-us-drug-enforcement-administration-and-us-a. Accessed May 31, 2012.
- Department of Health and Human Services. Paul D. Goldenheim, M.D., Howard R. Udell, Michael Friedman, Petitioners, -v. - Inspector General (DHHS), Civil Remedies CR1883, CR1884, CR1885, App. Div. Docket Nos. A-09–56, A-09–57, A-09–58 Decision No. 2268. 2009. Available at: http://www.hhs.gov/dab/decisions/dabdecisions/dab2268.pdf. Accessed June 6, 2012.
- Meier B. Narcotic maker guilty of deceit over marketing. The New York Times. 2007; May 11: Available at: http://www.nytimes.com/2007/05/11/business/11drug.html?pagewanted=all. Accessed on July 27, 2012.
- RADARS System. Overview. 2012. Available at: http://www.radars.org/Home2/Overview.aspx. Accessed June 6, 2012.
- Food and Drug Administration. FDA Approves New Formulation for OxyContin. 2010. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm207480.htm. Accessed June 6, 2012.
- Drug Enforcement Administration. ARCOS Retail Drug Summary. 2012. Available at: http://www.deadiversion. usdoj.gov/arcos/index.html. Accessed April 7, 2012.
- 21 CFR 1308. Food and Drugs, Part 1300 to End. 2011. Available at: http://www.gpo.gov/fdsys/pkg/CFR-2011-title21-vol9/pdf/CFR-2011-title21-vol9-part1308-toc-id200.pdf. Accessed March 27, 2012.
- 21 CFR 1304.33. Food and Drugs, Part 1300 to End. 2011. Available at: http://www.gpo.gov/fdsys/pkg/CFR-2011-title21-vol9/pdf/CFR-2011-title21-vol9-part1304.pdf. Accessed March 27, 2012.
- Wunsch MJ, Nakamoto K, Behonick G, Massello W. Opioid deaths in rural Virginia: a description of the high prevalence of accidental fatalities involving prescribed medications. Am J Addict. 2009;18:5–14.
- Wolf BC, Lavezzi WA, Sullivan LM, Flannagan LM. One hundred seventy two deaths involving the use of oxycodone in Palm Beach County. J Forensic Sci. Jan 2005;50:192–195.
- Toblin RL, Paulozzi LJ, Logan JE, Hall AJ, Kaplan JA. Mental illness and psychotropic drug use among prescription drug overdose deaths: a medical examiner chart review. J Clin Psychiatry. 2010;71:491–496.
- DHHS, Office of Inspector General. Fact Sheet: Federal Anti-Kickback Law and Regulatory Safe Harbors [42 USC 1320a-7b(b)]. 1999. Available at: http://oig.hhs.gov/ fraud/docs/safeharborregulations/safefs.htm. Accessed March 31, 2012.
- Cardinal Health Inc. v. Eric Holder, Jr., Attorney General, et al. U.S. District Court, District of Columbia, Case 1:12-cv-00185-RBW; Document 14–2; Filed 02/10/12 at p. 39. Washington, D.C. 2012.
- Cardinal Health Inc. v. Eric Holder, Jr., Attorney General, et al. U.S. District Court, District of Columbia, Case 1:12-cv-00185-RBW; Document 14; Filed 02/10/12 at pp. 39 of 49. Washington, D.C. 2012.
- United States Code. 21 USC 841, Prohibited Acts. 2010. Available at: http://www.gpo.gov/fdsys/pkg/USCODE-2010-title21/pdf/USCODE-2010-title21-chap13.pdf. Accessed June 8, 2012.
- U.S. Securities and Exchange Commission. Form 10Q: Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934; For the period ended March 31, 2012 (p. 13). 2012. Available at: http://www.sec.gov/Archives/edgar/data/353230/000144264312000039/ a10qq112.htm. Accessed June 8, 2012.
- United States Government Accountability Office. Prescription Drug Control: DEA Has Enhanced Efforts to Combat Diversion, but Could Better Assess and Report Program Results (Document No. GAO-11–744). 2011. Available at: http://www.gao.gov/products/GAO-11–744. Accessed June 8, 2012.
- U.S. Department of Justice, Office of the Inspector General, Audit Division. Audit of the Drug Enforcement Administration's Personnel Resource Management and Casework. 2011. Available at: http://www.justice.gov/oig/reports/2011/a1202.pdf. Accessed June 10, 2012.
- 21 USC 886a. Departments of Commerce, Justice, and State, the Judiciary, and Related Agencies Appropriations Act, 1993 (Pub. L. 102–395, title I, Sec. 111(b), Oct. 6, 1992, 106 Stat. 1843). 1993. Available at: http://www.deadiversion.usdoj.gov/21cfr/21usc/886a.htm. Accessed March 25, 2012.